- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Chapter 4 Factors that influence drug effects and principles for rational medication In general, factors influencing drug effects can be classified into two major groups: 1. Drug associated 2. Patients associated Drug Associated Formulations 制剂 Routes of drug administration 给药途经 Drug combination 合用药物 Formulations 制剂 (pharmaceutical preparations) Conventional dosage forms剂型: Tablet, Capsule, et cetera. Newly developed: slow-release 缓释 , extended-release延迟释放,sustained-release 持续释放, or controlled-release控释 preparations. 缓释剂(slow release formulation) 一级释放 延迟释放剂(extended release formulation) 缓慢释放为主 持续释放剂(sustained release formulation) 不同释放速率组合 控释剂(controlled release formulation) 零级释放 使用这些长效剂型可方便患者和维持长期疗效。 Routes of drug administration 给药途径 intravenous injection or infusion intramuscular injection subcutaneous injection oral ingestion Drug Incompatibility 配伍禁忌 A situation in which toxic substances emerges, or efficacy is reduced or lost because of direct physical or chemical interactions between two or more drugs mixed in vitro. A situation in which two or more of the ingredients of a drug interact chemically, with resulting deterioration of the mixture. The drugs react with each other and precipitate, produce gas or similar effect, or pharmacological in that the effects of the two on tissues are opposite, or pharmaceutical, e.g. immiscibility, insolubility. Pharmacokinetic Drug-Drug Interactions Drugs may interact at any point during their absorption, distribution, metabolism, or excretion; the result may be an increase or decrease in the concentration of drug at the site of action. As individuals vary in their rates of disposition of any given drug, the magnitude of an interaction that alters pharmacokinetic parameters is not always predictable, but it can be very significant. Measures should be taken.
您可能关注的文档
- “转型零售 再创辉煌”——2013年上海大众附件供应商会议佑华发言稿20131122.pptx
- 《壁画设计与制作》课件(五).ppt
- 1号地块项目定位与可行性报告--建于果岭之上的别墅.ppt
- 02上皮组织--Epithelial Tissue.ppt
- 003彩链房产物业辅助系统.ppt
- 004 彩链营销服务辅助系统.ppt
- 04血液(中文版)--全国高等学校教材.ppt
- 05软骨和骨--全国高等学校教材.ppt
- 006 彩链食品服务溯源系统.ppt
- 008 车辆附着应用.ppt
- Chpt 06 Introduction to Autonomic Pharmacology自律药介绍.ppt
- Chpt 07 Cholinoceptor-activating drugs胆碱受体激动剂.ppt
- Chpt 08中 Anticholinesterase drugs and cholinesterase reactivators抗胆碱酯酶药和胆碱酯酶复活药.ppt
- Chpt 09 Cholinoceptor-blocking drugs中胆碱受体阻断药.ppt
- Chpt 10 Adrennoceptor agonists中肾上腺素受体激动药.ppt
- Chpt 11 Adrenoceptor blocking drugs肾上腺素受体阻断药.ppt
- Chpt 13 The pharmacology of CNS中枢神经系统药理学概论.ppt
- Chpt 16 Antiepileptic Drugs1抗癫痫和抗惊厥药.ppt
- Chpt 19 NSAIDs解热镇痛药.ppt
- Chpt 41 中 General Considerations of Antimicrobial Agents--雷林生.ppt
文档评论(0)